Gastric cancer mechanisms involve ZFAS1-NKD2-Wnt/β-catenin axis activation that sustains proliferation, EMT, and chemoresistance, reversible by β-catenin overexpression [61]. Here, ZFAS1 is linked to gastric cancer.